Horizon Pharma to buy privately held Vidara for about $660 mln

March 19 Wed Mar 19, 2014 7:18am EDT

March 19 (Reuters) - Horizon Pharma Inc said it would buy privately held specialty pharmaceutical company Vidara Therapeutics International Ltd through a reverse merger for stock and cash valued at about $660 million.

Horizon Pharma said the resulting company, Horizon Pharma Plc, would be 26 percent owned by shareholders of Vidara, which has operations in Ireland and the United States. (Reporting By Vrinda Manocha in Bangalore; Editing by Sriraj Kalluvila)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.